关于 "nAChR" 的结果117+ 个结果
- COG 133 TFACAS: 2828432-37-5
COG 133 TFA 是载脂蛋白 E (Apolipoprotein E, APOE) 肽的片段。COG 133 与 ApoE 全息蛋白竞争结合 LDL 受体,具有有效的抗炎和神经保护作用。COG 133 TFA 也是 nAChR 拮抗剂,IC50 为 445 nM。
- Iptakalim hydrochlorideCAS: 642407-63-4
Iptakalim hydrochloride 是亲脂性的对氨基化合物,是 ATP 敏感的钾通道 (KATP) 的开放剂,也是包含α4β2 的烟碱乙酰胆碱受体 (nAChR)拮抗剂。
- BradaniclineCAS: 639489-84-2
Bradanicline 是一种高度选择性的 α7 烟碱乙酰胆碱受体 (nAChR) 激动剂 (对人 α7 nAChR 的 EC50=17 nM; Ki= 1.4 nM)。Bradanicline 可用于研究认知障碍。
- Galantamine (hydrobromide)CAS: 69353-21-5
An alkaloid with AChE inhibitory and nAChR potentiating activities
- (S)-(-)-LevamisoleCAS: 14769-73-4
(S)-(-)-Levamisole (Levamisole),一种驱虫剂,具有免疫调节特性的。(S)-(-)-Levamisole 作为 α3β2 (EC50=300 μM) 和 α3β4 (EC50=100 μM) 的正变构调节剂 (PAM) ) nAChRs 的亚型。具有口服活性。
- α-Conotoxin PnIA (trifluoroacetate salt)
A peptide antagonist of α3β2-subunit containing and α7 nAChRs
- Simufilam dihydrochlorideCAS: 2480226-06-8
Simufilam (PTI-125) Dihydrochloride is a small molecule modulator that preferentially binds altered FLNA and restores its native conformation, restoring receptor and synaptic activities and reducing its α7nAChR/TLR4 associations and downstream pathologies.
- Varenicline (CP 526555) dihydrochlorideCAS: 866823-63-4
Varenicline (CP 526555, Chantix, Champix,CP 526555 dihydrochloride) dihydrochloride is a potent, partial agonist of α4β2 nicotinic acetylcholine receptor (nAChR) and α3β4 nAChR with EC50 of 2.3 μM and 55 μM, respectively. Varenicline dihydrochloride is a potent, full agonist of α7 nAChRs with EC50 of 18 μM. Varenicline is a prescription medication used for smoking cessation.
- α-Conotoxin GICAS: 76862-65-2
α-Conotoxin GI, a 13-residue peptide originally isolated from the venom of the fish-hunting cone snail Conus geographus, acts as a competitive antagonist for the muscle-type nicotinic acetylcholine receptor (nAChR) with excellent selectivity for α/δ receptor subunit binding over α/γ.
- AT 1001CAS: 1314801-63-2
High affinity and selective α3β4 nAChR ligand (Ki value 2.6 nM at α3β4 nAChR) with both partial agonistic and antagonistic effects, and >90-fold selective over the other major subtypes, the α4β2 and α7 nAChR. AT-1001 potently and dose-dependently blocks nicotine self-administration in rats, without affecting food responding, and shows a mechanism of action very different from varenicline (Varenicline dihydrochloride (HCl salt) and AT 1001 (tartrate salt)).
- PHA 543613 dihydrochlorideCAS: 478148-58-2
Potent and selective α7 nicotinic acetylcholine receptor (nAChR) agonist, which is characterized by rapid brain penetration and high oral bioavailability; a potential treatment of cognitive deficits in schizophrenia
- (S)-VQW-765
(S)-VQW-765 ((S)-AQW-051) 是一种具有口服活性、选择性和有效性的 α7 烟碱 Ach 受体 (nAChR) 部分激动剂。(S)-VQW-765 在神经疾病相关的认知障碍中有潜在的应用,例如阿尔茨海默病或精神分裂症。
- TribendimidineCAS: 115103-15-6
Tribendimidine 一种广谱的、具有口服活性的驱虫剂,对 A. lumbricoides 和 N. americanus 具有特别高的活性。Tribendimidine 也是 L 型烟碱乙酰胆碱受体 (nAChR) 激动剂。
- α7 Nicotinic receptor agonist-1CAS: 220100-05-0
α7 Nicotinic receptor agonist-1 (Preparation 5) 是一种 α7 nAChR 激动剂。α7 Nicotinic receptor agonist-1 可用于精神障碍 (如精神分裂症、躁狂或躁狂抑郁症和焦虑症) 和智力障碍 (如阿尔茨海默氏病、学习缺陷、认知缺陷、注意力缺陷、记忆丧失、路易体痴呆和注意力缺陷多动症) 的研究。
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC63868 | COG 133 TFA | 2828432-37-5 | nAChR | ||
COG 133 TFA 是载脂蛋白 E (Apolipoprotein E, APOE) 肽的片段。COG 133 与 ApoE 全息蛋白竞争结合 LDL 受体,具有有效的抗炎和神经保护作用。COG 133 TFA 也是 nAChR 拮抗剂,IC50 为 445 nM。 | |||||
| GC63928 | Iptakalim hydrochloride | 642407-63-4 | nAChR | ||
Iptakalim hydrochloride 是亲脂性的对氨基化合物,是 ATP 敏感的钾通道 (KATP) 的开放剂,也是包含α4β2 的烟碱乙酰胆碱受体 (nAChR)拮抗剂。 | |||||
| GC64064 | Bradanicline | 639489-84-2 | nAChR | ||
Bradanicline 是一种高度选择性的 α7 烟碱乙酰胆碱受体 (nAChR) 激动剂 (对人 α7 nAChR 的 EC50=17 nM; Ki= 1.4 nM)。Bradanicline 可用于研究认知障碍。 | |||||
| GC52078 | Galantamine (hydrobromide) | 69353-21-5 | Behavioral Neuroscience | ||
An alkaloid with AChE inhibitory and nAChR potentiating activities | |||||
| GC64394 | Flupyrimin | 1689566-03-7 | nAChR | ||
Flupyrimin(FLP)是一种具有三氟乙酰基药效团的新型杀虫剂,是昆虫烟碱乙酰胆碱受体(nAChR)的拮抗剂。 | |||||
| GC64735 | (S)-(-)-Levamisole | 14769-73-4 | nAChR | ||
(S)-(-)-Levamisole (Levamisole),一种驱虫剂,具有免疫调节特性的。(S)-(-)-Levamisole 作为 α3β2 (EC50=300 μM) 和 α3β4 (EC50=100 μM) 的正变构调节剂 (PAM) ) nAChRs 的亚型。具有口服活性。 | |||||
| GC66073 | Flupyradifurone | 951659-40-8 | nAChR | ||
Flupyradifurone 是一种 nAChR 激动剂,可干扰害虫中枢神经系统的信号转导,可用作杀虫剂。 | |||||
| GC52338 | α-Conotoxin PnIA (trifluoroacetate salt) | - | Cancer Biology | ||
A peptide antagonist of α3β2-subunit containing and α7 nAChRs | |||||
| GC25935 | Simufilam dihydrochloride | 2480226-06-8 | Actin | ||
Simufilam (PTI-125) Dihydrochloride is a small molecule modulator that preferentially binds altered FLNA and restores its native conformation, restoring receptor and synaptic activities and reducing its α7nAChR/TLR4 associations and downstream pathologies. | |||||
| GC26032 | Varenicline (CP 526555) dihydrochloride | 866823-63-4 | AChR | ||
Varenicline (CP 526555, Chantix, Champix,CP 526555 dihydrochloride) dihydrochloride is a potent, partial agonist of α4β2 nicotinic acetylcholine receptor (nAChR) and α3β4 nAChR with EC50 of 2.3 μM and 55 μM, respectively. Varenicline dihydrochloride is a potent, full agonist of α7 nAChRs with EC50 of 18 μM. Varenicline is a prescription medication used for smoking cessation. | |||||
| GC26093 | α-Conotoxin GI | 76862-65-2 | AChR | ||
α-Conotoxin GI, a 13-residue peptide originally isolated from the venom of the fish-hunting cone snail Conus geographus, acts as a competitive antagonist for the muscle-type nicotinic acetylcholine receptor (nAChR) with excellent selectivity for α/δ receptor subunit binding over α/γ. | |||||
| GB40105 | AT 1001 | 1314801-63-2 | - | ||
High affinity and selective α3β4 nAChR ligand (Ki value 2.6 nM at α3β4 nAChR) with both partial agonistic and antagonistic effects, and >90-fold selective over the other major subtypes, the α4β2 and α7 nAChR. AT-1001 potently and dose-dependently blocks nicotine self-administration in rats, without affecting food responding, and shows a mechanism of action very different from varenicline (Varenicline dihydrochloride (HCl salt) and AT 1001 (tartrate salt)). | |||||
| GB40320 | PHA 543613 dihydrochloride | 478148-58-2 | - | ||
Potent and selective α7 nicotinic acetylcholine receptor (nAChR) agonist, which is characterized by rapid brain penetration and high oral bioavailability; a potential treatment of cognitive deficits in schizophrenia | |||||
| GC20230 | α-Bungarotoxin | 11032-79-4 | - | ||
α-Bungarotoxin 是烟碱乙酰胆碱受体 (nAChRs) 的竞争性拮抗剂。 | |||||
| GC69979 | (S)-VQW-765 | - | nAChR | ||
(S)-VQW-765 ((S)-AQW-051) 是一种具有口服活性、选择性和有效性的 α7 烟碱 Ach 受体 (nAChR) 部分激动剂。(S)-VQW-765 在神经疾病相关的认知障碍中有潜在的应用,例如阿尔茨海默病或精神分裂症。 | |||||
| GC70059 | Tribendimidine | 115103-15-6 | nAChR | ||
Tribendimidine 一种广谱的、具有口服活性的驱虫剂,对 A. lumbricoides 和 N. americanus 具有特别高的活性。Tribendimidine 也是 L 型烟碱乙酰胆碱受体 (nAChR) 激动剂。 | |||||
| GC70130 | VQW-765 | 669770-29-0 | nAChR | ||
VQW-765 (AQW-051) 是一种选择性的、具有口服活性的 alpha-7 烟碱乙酰胆碱受体 (α7-nAChR) 激动剂,对重组表达的人 α7-nAChR 的 pKD 值为 7.56。VQW-765 在体内表现出抗焦虑作用。VQW-765 可用于焦虑障碍和急性焦虑的研究。 | |||||
| GC70179 | α7 Nicotinic receptor agonist-1 | 220100-05-0 | nAChR | ||
α7 Nicotinic receptor agonist-1 (Preparation 5) 是一种 α7 nAChR 激动剂。α7 Nicotinic receptor agonist-1 可用于精神障碍 (如精神分裂症、躁狂或躁狂抑郁症和焦虑症) 和智力障碍 (如阿尔茨海默氏病、学习缺陷、认知缺陷、注意力缺陷、记忆丧失、路易体痴呆和注意力缺陷多动症) 的研究。 | |||||
| GC90121 | (±)-Anabasine (hydrochloride) | - | Natural Products | ||
一种具有致畸作用的nAChRs生物碱激动剂。 | |||||
| GC70230 | Br-PBTC | 1839519-57-1 | nAChR | ||
Br-PBTC是一种有效的、2/4亚型选择性的nAChRs(烟碱乙酰胆碱受体)正变质调节剂,其α2β2、α2β4、α4β2、(α4β2)2α4 β2和(α4β2)2β2 EC50范围为0.1~0.6 μM。 | |||||
| GC70459 | Sulfoxaflor | 946578-00-3 | nAChR | ||
Sulfoxaflor是一种磺酰亚胺杀虫剂,是nAChR1和nAChR2亚型的激动剂。 | |||||
